Compounds > tenofovir
Page last updated: 2024-08-24

tenofovir and pradefovir mesylate

tenofovir has been researched along with pradefovir mesylate in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Chen, L; Ding, Y; Wang, D; Xiao, Q; Yang, J; Yang, W1
Chen, H; Ding, Y; Jin, W; Li, C; Li, X; Liu, C; Liu, J; Niu, J; Wu, M; Zhang, D; Zhang, H; Zhu, X1
Chen, L; Chen, W; Cui, H; Ding, Y; Gao, Y; Gong, H; Han, T; Jia, J; Jin, W; Jin, X; Jin, Z; Kong, F; Li, G; Liu, C; Liu, W; Mao, Q; Mu, M; Niu, J; Peng, Y; Shang, J; Song, X; Wang, D; Wang, P; Wen, X; Wu, X; Xia, J; Yan, X; Yang, Y; Yao, L; Zhang, D; Zhang, Z; Zhao, C; Zhu, Q1

Trials

3 trial(s) available for tenofovir and pradefovir mesylate

ArticleYear
Simultaneous determination of pradefovir, PMEA and tenofovir in HBV patient serum using liquid chromatography-tandem mass spectrometry and application to phase 2 clinical trial.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2016, Jun-01, Volume: 1022

    Topics: Adenine; Adult; Chromatography, High Pressure Liquid; Drug Stability; Female; Humans; Linear Models; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Prodrugs; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Tenofovir

2016
Safety, efficacy, and pharmacokinetics of pradefovir for the treatment of chronic hepatitis B infection.
    Antiviral research, 2020, Volume: 174

    Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Prodrugs; Tenofovir; Treatment Outcome; Viral Load

2020
Pradefovir Treatment in Patients With Chronic Hepatitis B: Week 24 Results From a Multicenter, Double-Blind, Randomized, Noninferiority, Phase 2 Trial.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 06-10, Volume: 74, Issue:11

    Topics: Adenine; Antiviral Agents; DNA, Viral; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Organophosphorus Compounds; Prodrugs; Tenofovir; Treatment Outcome; Viral Load

2022